HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative carcinogenicity of picene and dibenz[a,h]anthracene in the rat.

Abstract
Early carcinogenicity tests found no evidence of activity for picene but found considerable initiating and carcinogenic activity for dibenz[a,h]anthracene (DBA). More recent investigation suggested that both pentacyclics were complete carcinogens when administered as single sc injections in NMRI mice, despite findings that picene acted as neither an initiating nor promoting agent. To investigate this contradiction, the complete carcinogenicities of both isomers were compared by sc injection in female Sprague-Dawley rats. The results demonstrate that 1 micromol of DBA, administered three times weekly for 20 doses, induces sarcomas in all test animals by 33 weeks (100%). Similar treatment with picene did not induce sarcoma in any test animals by 37 weeks (0%). The present results agree with the earlier studies. It follows from these results that the predictions of the unified theory for the appearance of carcinogenic properties following administration of picene and dibenz[a,h]anthracene to test animals have been confirmed.
AuthorsJames W Flesher, Jamie Horn, Andreas F Lehner
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 290 Issue 1 Pg. 275-9 (Jan 11 2002) ISSN: 0006-291X [Print] United States
PMID11779165 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Copyright(c)2002 Elsevier Science.
Chemical References
  • Benz(a)Anthracenes
  • Carcinogens
  • Chrysenes
  • Hydrocarbons
  • picene
  • 1,2,5,6-dibenzanthracene
Topics
  • Animals
  • Benz(a)Anthracenes
  • Carcinogens
  • Chromatography, High Pressure Liquid
  • Chrysenes
  • Dose-Response Relationship, Drug
  • Female
  • Hydrocarbons
  • Models, Chemical
  • Neoplasms (chemically induced)
  • Rats
  • Rats, Sprague-Dawley
  • Structure-Activity Relationship
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: